← Back to Search

Behavioral Intervention

Culturally Tailored HPV Education for Vaccine Uptake

N/A
Recruiting
Led By Eva M Moya, PhD, LMSW
Research Sponsored by University of Texas, El Paso
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Adults between the ages 18 and 45 years old
Adults who have not completed the HPV vaccine series (unvaccinated or under-vaccinated)
Must not have
Adults older than 45 years of age
Adults who are unable to participate in the full study intervention and follow-up time-points
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention
Awards & highlights
No Placebo-Only Group

Summary

This trial studies the impact of multimedia stories on HPV vaccination rates among 18-45yo in the El Paso US-Mexico border region.

Who is the study for?
This trial is for adults aged 18-45 who live or work in El Paso County, Texas and haven't finished their HPV vaccine series. It's not for those under 18 or over 45, non-residents of El Paso, or anyone who took part in earlier phases of this research.
What is being tested?
The study compares two educational videos about HPV vaccination: one tailored to the local culture and another general information video. The goal is to see if the culturally tailored version leads to higher vaccination rates.
What are the potential side effects?
Since this trial focuses on education rather than medication, there are no direct side effects from interventions. However, participants may experience discomfort discussing personal health decisions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 45 years old.
Select...
I have not completed the HPV vaccine series.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am older than 45 years.
Select...
I cannot commit to the full study schedule.
Select...
I can complete study activities in English or Spanish.
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-assessment), immediately post-intervention (0 months), 1 month post-intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Between-group changes in proportions from baseline scores on the Vaccination Decision Stage scale and post-intervention scores of the Community Intervention Survey.
Secondary study objectives
Between-group changes in proportions from baseline scores on the HPV Knowledge scale and post-intervention scores of the Community Intervention Survey.
Between-group changes in proportions from baseline scores on the HPV Vaccine Attitudes scale and post-intervention scores of the Community Intervention Survey.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
A tailored HPV psychoeducational multimedia intervention
Group II: Active ControlActive Control1 Intervention
General/standard multimedia materials on HPV and HPV vaccine

Find a Location

Who is running the clinical trial?

University of Texas, El PasoLead Sponsor
15 Previous Clinical Trials
2,859 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
428 Previous Clinical Trials
1,371,022 Total Patients Enrolled
Eva M Moya, PhD, LMSWPrincipal InvestigatorThe University of Texas at El Paso, Border Biomedical Research Center
1 Previous Clinical Trials
150 Total Patients Enrolled
~67 spots leftby Oct 2025